BrightSpring Health Services, Inc. (NASDAQ: BTSG) increased its full-year 2026 guidance after reporting first-quarter financial results that suggest a strengthening position in the home and community-based health services sector. The company’s positive outlook, which lifted revenue projections by over $200 million, comes as the health services industry navigates a complex post-pandemic landscape.
"Our strong first-quarter performance provides a solid foundation for the remainder of the year," a company spokesperson said in the press release. "The increased guidance reflects our confidence in our operating model and the growing demand for our services."
The company now expects full-year 2026 revenue to reach $14.85 billion, an increase from the previous estimate of $14.62 billion. More significantly, earnings per share guidance saw a substantial 23 percent lift to $1.32 from a prior $1.07. For the first quarter, analysts had forecast revenue of $3.39 billion and earnings of $0.30 per share. This follows a fourth quarter where BrightSpring beat revenue expectations by nearly 5 percent.
The guidance increase suggests BrightSpring is effectively managing costs and capturing demand in a sector where rivals like The Cigna Group (NYSE: CI) also recently reported strong results. Cigna beat its own first-quarter earnings and revenue estimates, posting an EPS of $7.79 on revenue of $68.49 billion. The broad strength indicates robust demand for health services, a positive sign for the industry's economic underpinning.
Analysts maintain a consensus "Outperform" rating on BrightSpring, with an average price target of $52.27, implying an 8.55 percent upside from its current price of $48.15. The upgraded guidance may lead to upward revisions of these targets as analysts digest the company’s improved profitability outlook.
This article is for informational purposes only and does not constitute investment advice.